Simulations Plus Inc (SLP)

$12.99 +0.19 (1.48%)
Market Cap 257.63M
Revenue (ttm) 70.01M
Net Income (ttm) 9.95M
EPS (ttm) N/A
PE Ratio 13.15
Forward PE 13.15
Profit Margin 14.21%
Debt to Equity Ratio 0.00
Volume 301,100
Avg Vol 724,304
Day's Range N/A - N/A
Shares Out 20.13M
Stochastic %K 36%
Beta 0.76
Analysts Strong Sell
Price Target $25.33

Company Profile

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides prod...

Industry: Health Information Services
Sector: Healthcare
Phone: 661 723 7723
Address:
800 Park Offices Drive, Suite 401, Research Triangle Park, United States
AnalyticaInvestor
AnalyticaInvestor Aug. 4 at 10:50 AM
$SLP $RCKT $PEPG $QMCO 🧬 Biotech & Tech Bounceback? $SLP, $PEPG, $RCKT all down 50–75%+ YTD but showing signs of life. From AI-driven drug discovery to gene therapy breakthroughs, these high-risk plays are drawing fresh attention. $QMCO popped 10% despite an –86% YTD collapse, reminding investors that small caps can move fast in both directions. Catching a falling knife or finding deep value? 📊 Read the full Analytica Investor for all the insights 👇 https://analyticainvestor.beehiiv.com/p/you-re-fired-3502b8c8dd61d73c
1 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jul. 29 at 11:56 AM
$SLP Simulations Plus Announces Publication Of Experimental Results Of AIDD Collaboration With IMB PAS In ACS Medical Chemistry Letters
0 · Reply
Bazzzigar
Bazzzigar Jul. 27 at 7:41 PM
$SLP $20+ soon
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 23 at 5:52 PM
$SLP Excellent article that nails exactly where SLP stands right now. So if you want to update your SLP knowledge or get acquainted with SLP, this is a must read. https://beyondspx.com/article/simulations-plus-ai-powered-evolution-amidst-market-headwinds-nasdaq-slp
0 · Reply
fer69
fer69 Jul. 22 at 8:08 PM
$SLP bought 300 shares today at $13.06 average …. New position here
1 · Reply
r202950
r202950 Jul. 22 at 7:21 PM
$SLP
0 · Reply
andftbl
andftbl Jul. 22 at 12:21 PM
$SLP reversal?
0 · Reply
ekiss33
ekiss33 Jul. 21 at 6:40 PM
$SLP Back to 23 by next week!!! LFG!!!!
1 · Reply
nct
nct Jul. 19 at 8:52 PM
$SLP was the change in CPA an underlying reason for this big drop after ER?Why did the company go back to their earlier Accounting Firm who they had dismissed hardly 3 months back? https://www.sec.gov/ix?doc=/Archives/edgar/data/0001023459/000102345925000047/slp-20250709.htm
0 · Reply
Gil_Mars
Gil_Mars Jul. 19 at 3:21 AM
$SLP I’m trying to find my cat
0 · Reply
Latest News on SLP
Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman

Aug 1, 2025, 12:58 PM EDT - 3 days ago

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman

SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm

Jul 31, 2025, 3:13 PM EDT - 4 days ago

SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design

Jul 29, 2025, 7:50 AM EDT - 6 days ago

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design

Simulations Plus: Still Positioned For FDA In‑Silico Trend Despite Near‑Term Headwinds

Jul 17, 2025, 5:55 AM EDT - 18 days ago

Simulations Plus: Still Positioned For FDA In‑Silico Trend Despite Near‑Term Headwinds

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Jul 15, 2025, 1:56 PM EDT - 20 days ago

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Jul 15, 2025, 8:40 AM EDT - 20 days ago

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

FBK

Simulations Plus, Inc. (SLP) Q3 2025 Earnings Call Transcript

Jul 14, 2025, 8:29 PM EDT - 21 days ago

Simulations Plus, Inc. (SLP) Q3 2025 Earnings Call Transcript

Simulations Plus Invests in Clinical Development Technology Company Nurocor

Jul 14, 2025, 4:15 PM EDT - 21 days ago

Simulations Plus Invests in Clinical Development Technology Company Nurocor

Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

Jul 14, 2025, 4:05 PM EDT - 21 days ago

Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call

Jun 18, 2025, 4:05 PM EDT - 6 weeks ago

Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call

Simulations Plus: Further Downside Is Likely (Rating Downgrade)

Jun 13, 2025, 8:45 AM EDT - 7 weeks ago

Simulations Plus: Further Downside Is Likely (Rating Downgrade)

Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt

Jun 12, 2025, 2:15 PM EDT - 7 weeks ago

Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt

Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

Jun 12, 2025, 7:50 AM EDT - 7 weeks ago

Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

Jun 11, 2025, 4:30 PM EDT - 7 weeks ago

Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

Simulations Plus Releases ADMET Predictor® 13

Jun 5, 2025, 7:50 AM EDT - 2 months ago

Simulations Plus Releases ADMET Predictor® 13

Simulations Plus Releases DILIsym® 11

May 15, 2025, 7:50 AM EDT - 2 months ago

Simulations Plus Releases DILIsym® 11

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Apr 21, 2025, 7:50 AM EDT - 3 months ago

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Simulations Plus: Benefiting From FDA Modernization And AI

Apr 16, 2025, 8:30 AM EDT - 3 months ago

Simulations Plus: Benefiting From FDA Modernization And AI

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

Apr 11, 2025, 10:44 AM EDT - 4 months ago

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

CERT CRL

Simulations Plus: I See Promising Growth, But I'm Staying Neutral

Apr 4, 2025, 11:24 AM EDT - 4 months ago

Simulations Plus: I See Promising Growth, But I'm Staying Neutral

Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript

Apr 3, 2025, 8:44 PM EDT - 4 months ago

Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript

Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

Apr 3, 2025, 4:05 PM EDT - 4 months ago

Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

Top 3 Health Care Stocks That Are Set To Fly This Month

Mar 26, 2025, 7:06 AM EDT - 4 months ago

Top 3 Health Care Stocks That Are Set To Fly This Month

ARVN IOVA

Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

Mar 20, 2025, 7:00 AM EDT - 4 months ago

Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum

Mar 10, 2025, 7:00 AM EDT - 5 months ago

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

Feb 4, 2025, 7:30 AM EST - 6 months ago

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

Jan 22, 2025, 7:50 AM EST - 6 months ago

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

Jan 13, 2025, 7:13 PM EST - 7 months ago

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

Simulations Plus Supported Development of Every FDA-Approved Drug in 2024

Jan 13, 2025, 7:50 AM EST - 7 months ago

Simulations Plus Supported Development of Every FDA-Approved Drug in 2024

Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript

Jan 7, 2025, 9:08 PM EST - 7 months ago

Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

Jan 7, 2025, 4:06 PM EST - 7 months ago

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

Dec 17, 2024, 4:06 PM EST - 8 months ago

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

Simulations Plus to Participate in the BTIG Digital Health Forum

Nov 19, 2024, 8:30 AM EST - 9 months ago

Simulations Plus to Participate in the BTIG Digital Health Forum

ESG

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

Nov 13, 2024, 8:30 AM EST - 9 months ago

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

ESG

Simulations Plus to Participate in the Stephens Annual Investment Conference

Nov 6, 2024, 8:30 AM EST - 9 months ago

Simulations Plus to Participate in the Stephens Annual Investment Conference

ESG

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

Oct 30, 2024, 8:30 AM EDT - 9 months ago

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

ESG

Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript

Oct 23, 2024, 11:55 PM EDT - 10 months ago

Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

Oct 23, 2024, 4:06 PM EDT - 10 months ago

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

Oct 9, 2024, 4:06 PM EDT - 10 months ago

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

ESG

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

Oct 8, 2024, 8:30 AM EDT - 10 months ago

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

ESG

Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions

Aug 23, 2024, 8:00 AM EDT - 1 year ago

Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions

Simulations Plus Releases DILIsym® X

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Simulations Plus Releases DILIsym® X

Simulations Plus Releases ADMET Predictor® Version 12

Jul 30, 2024, 8:30 AM EDT - 1 year ago

Simulations Plus Releases ADMET Predictor® Version 12

Simulations Plus to Participate in KeyBanc's 25th Annual Technology Leadership Forum

Jul 25, 2024, 8:30 AM EDT - 1 year ago

Simulations Plus to Participate in KeyBanc's 25th Annual Technology Leadership Forum

Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety

Jul 11, 2024, 8:30 AM EDT - 1 year ago

Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety

Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jul 3, 2024, 8:53 AM EDT - 1 year ago

Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

FFWM

AnalyticaInvestor
AnalyticaInvestor Aug. 4 at 10:50 AM
$SLP $RCKT $PEPG $QMCO 🧬 Biotech & Tech Bounceback? $SLP, $PEPG, $RCKT all down 50–75%+ YTD but showing signs of life. From AI-driven drug discovery to gene therapy breakthroughs, these high-risk plays are drawing fresh attention. $QMCO popped 10% despite an –86% YTD collapse, reminding investors that small caps can move fast in both directions. Catching a falling knife or finding deep value? 📊 Read the full Analytica Investor for all the insights 👇 https://analyticainvestor.beehiiv.com/p/you-re-fired-3502b8c8dd61d73c
1 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jul. 29 at 11:56 AM
$SLP Simulations Plus Announces Publication Of Experimental Results Of AIDD Collaboration With IMB PAS In ACS Medical Chemistry Letters
0 · Reply
Bazzzigar
Bazzzigar Jul. 27 at 7:41 PM
$SLP $20+ soon
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 23 at 5:52 PM
$SLP Excellent article that nails exactly where SLP stands right now. So if you want to update your SLP knowledge or get acquainted with SLP, this is a must read. https://beyondspx.com/article/simulations-plus-ai-powered-evolution-amidst-market-headwinds-nasdaq-slp
0 · Reply
fer69
fer69 Jul. 22 at 8:08 PM
$SLP bought 300 shares today at $13.06 average …. New position here
1 · Reply
r202950
r202950 Jul. 22 at 7:21 PM
$SLP
0 · Reply
andftbl
andftbl Jul. 22 at 12:21 PM
$SLP reversal?
0 · Reply
ekiss33
ekiss33 Jul. 21 at 6:40 PM
$SLP Back to 23 by next week!!! LFG!!!!
1 · Reply
nct
nct Jul. 19 at 8:52 PM
$SLP was the change in CPA an underlying reason for this big drop after ER?Why did the company go back to their earlier Accounting Firm who they had dismissed hardly 3 months back? https://www.sec.gov/ix?doc=/Archives/edgar/data/0001023459/000102345925000047/slp-20250709.htm
0 · Reply
Gil_Mars
Gil_Mars Jul. 19 at 3:21 AM
$SLP I’m trying to find my cat
0 · Reply
LucienW
LucienW Jul. 18 at 8:52 PM
$PSNL once reimbursements are approved this should easily achieve annual revenue north of 200m. Until then, looks like there will be quite some ups and downs. I am rather concerned about the upcoming ER call. We might need to dial down our expectations re reimbursement progress, both submissions and approvals. While I’m still very bullish in the mid to long term, I did offload a bit this week (along with a few other tickers), mostly to fund my $SLP purchases.
2 · Reply
Drugtrade
Drugtrade Jul. 18 at 8:47 PM
$SLP i stopped out today 😳 .. can it drop to $10 ??
1 · Reply
LucienW
LucienW Jul. 18 at 8:25 PM
$SLP what a week. Bought a ton. With dividend yield close to 2%, how far can this drop?
1 · Reply
ekiss33
ekiss33 Jul. 18 at 2:06 PM
$SLP They beat their earnings and drop 35% come on man!!! This should be over 20
0 · Reply
ekiss33
ekiss33 Jul. 18 at 2:04 PM
$SLP https://www.defenseworld.net/2025/07/18/stephens-cuts-simulations-plus-nasdaqslp-price-target-to-20-00.html
0 · Reply
mrjamesgriffith
mrjamesgriffith Jul. 18 at 10:57 AM
$SLP if we get a 20% gain the 15.00 calls would be in the money today💰🤑 is there enough bulls to push through the invisible ceilings? Options are expiring and nobody likes to leave empty handed.
0 · Reply
6pillbillsbro
6pillbillsbro Jul. 17 at 6:03 PM
$SLP Been absolutely smoked, but I do like the balance sheet and am short puts post earnings. Have never understood how a drop in price target from 28 to 20 from an analyst warrants a drop to 12.
1 · Reply
mrjamesgriffith
mrjamesgriffith Jul. 17 at 1:48 PM
$SLP so those call options are just going to expire tomorrow without any fight? Wow...I had hoped for more.
0 · Reply
Bazzzigar
Bazzzigar Jul. 17 at 1:15 PM
$SLP $30+ soon
0 · Reply
mrjamesgriffith
mrjamesgriffith Jul. 17 at 12:56 PM
$SBET when you know. You know. My 2nd magic trick is $SLP and it hasn't left the train station yet. All aboard!!
0 · Reply
mrjamesgriffith
mrjamesgriffith Jul. 17 at 12:11 PM
$SLP how's everyone doing? Good luck to all!
0 · Reply
crosby22
crosby22 Jul. 16 at 11:34 PM
$SLP what does the huge volume at closing tells us?
0 · Reply